Skip to main content
Blog Articles

Brought to you by Fresenius Kabi

Healthcare providers and patients can expect the same efficacy and safety from a biosimilar as from the…

Brought to you by Puma Biotechnology, Inc.

Looking for additional support tools for your patients taking NERLYNX® (neratinib)? The…

In ER+/HER2- metastatic breast cancer (mBC)

COULD ADVANCEMENTS IN ENDOCRINE…

Brought to you by Janssen Oncology

Subcutaneous Treatment for Multiple Myeloma

Janssen Oncology

April 27, 2021…

Brought to you by Research To Practice

Join Dr Neil Love and 29 invited clinical investigators for the continuation of this unique 11-…

Brought to you by Physicians' Education Resource®, LLC 

Although multiple myeloma (MM) remains incurable, the past 15 years have yielded…

Brought to you by BD

In today’s demanding, fast-paced hospitals, clinicians can benefit from any added efficiencies, especially with…

Brought to you by Advanced Accelerator Applications

Advanced Accelerator Applications (AAA) is an innovative medicines company focused…

Brought to you by GSK

Please join our BLENREP belantamab mafodotin-blmf presentation on Thursday, April 29th at 3:00 PM.